-

North America Construction Industry Report 2024: The $2,585 Billion Market is Set to Grow at a CAGR of 3.7% to 2028, Aided by Growing Investments in Non-residential Sectors - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Construction Market Size, Share, Trends, Analysis Report By Sector, Country, and Segment Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering.

The North America construction market size will be evaluated at $2,585.8 billion in 2024. The construction market in the North America region is expected to grow at a CAGR of 3.7% during 2024-2028.

The North America construction market report provides an executive-level overview of the current state of the construction sector in the region, with detailed forecasts of key indicators up to 2028. Published annually, the report provides a detailed analysis of the near-term opportunities, project pipeline, and evolution of demand by sector and country across regional markets.

The regional growth is set to be aided by growing investments in the non-residential sector, particularly in areas such as manufacturing and transportation.

Scope

  • North America construction market outlook: analysis as well as historical figures and forecasts of opportunities from the sector and regional segments.
  • The report provides an overview of the outlook for the North America construction industry to 2028.
  • Analysis of the construction output values (Real) in major countries: Canada and the US.
  • Insight into the sectoral movement covering commercial construction, energy and utilities construction, industrial construction, infrastructure construction, institutional construction, and residential construction.
  • Dedicated section covering key industry participants by country including top consultants and contractors.

Reasons to Buy

  • Evaluate regional trends in construction development from insight into output values and project pipelines. Identify the fastest growers to enable assessment and targeting of commercial opportunities in the markets best suited to strategic focus.
  • Identify the drivers in the North America construction market and consider growth in developed economies. Formulate plans on where and how to engage with the market while minimizing any negative impact on revenues.
  • Accompanying the analyst's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in the North America construction market.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Construction Outlook

2.1. All Construction

2.2. Commercial Construction

2.3. Energy and Utilities Construction

2.4. Industrial Construction

2.5. Infrastructure Construction

2.6. Institutional Construction

2.7. Residential Construction

Chapter 3 Construction Outlook - Country Level

3.1. Canada

3.1.1. Construction Market Overview

3.1.2. Key Industry Participants

3.2. US

3.2.1. Construction Market Overview

3.2.2. Key Industry Participants

Chapter 4 North America Construction Regional Trends

4.1. North America Construction Market Data

4.1.1. Canada Construction Market Data

4.1.2. US Construction Market Data

Chapter 5 Research Methodology

5.1. Introduction

5.2. Research Methodology Steps

5.2.1. Data Collection and Consolidation

5.2.2. Modeling and Estimation

5.2.3. Forecasting and Validation

For more information about this report visit https://www.researchandmarkets.com/r/udcxyc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Bioremediation Technology & Services Global Strategic Business Report 2026 | Now Available with Latest Forecasts to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bioremediation Technology & Services - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Bioremediation Technology & Services was valued at US$58.6 Billion in 2024 and is projected to reach US$87.5 Billion by 2030, growing at a CAGR of 6.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions...

North America B2C & B2B E-Commerce, Payments & AI Market Analysis Report 2026: Payments Landscape Shifts as Wallet Usage Rises but Cards Maintain Revenue Lead - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America B2C & B2B E-Commerce, Payments & AI" report has been added to ResearchAndMarkets.com's offering. This report analyzes how digital commerce, the evolving payments landscape, artificial intelligence, and B2B digital trade are reshaping retail, financial services, and enterprise operations across North America, providing in-depth coverage of market development, transaction infrastructure, consumer and business behavior, AI integration, and cross-...

Next Generation Drug Conjugates Market Trends and Global Forecasts, 2025-2035 - Lutathera, Pluvicto, Givlaari, Oxlumo, Leqvio, and Amvuttra Represent Milestones in Advanced Treatment Solutions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035" has been added to ResearchAndMarkets.com's offering. The global next-generation drug conjugates market is projected to surge from USD 4.2 billion in the current year to USD 15.5 billion by 2035, displaying a CAGR of 14.0% during the forecast period. Next-generation drug conjugates are emerging as significant targeted treatments, particularly for rare diseases and various cancer...
Back to Newsroom